190 related articles for article (PubMed ID: 12795053)
1. Cyclooxygenase-2 in lung cancer.
Dubinett SM; Sharma S; Huang M; Dohadwala M; Pold M; Mao JT
Prog Exp Tumor Res; 2003; 37():138-62. PubMed ID: 12795053
[No Abstract] [Full Text] [Related]
2. Multifaceted roles of cyclooxygenase-2 in lung cancer.
Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture.
Brown JR; DuBois RN
Chest; 2004 May; 125(5 Suppl):134S-40S. PubMed ID: 15136465
[No Abstract] [Full Text] [Related]
4. Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract.
Altorki NK; Subbaramaiah K; Dannenberg AJ
Prog Exp Tumor Res; 2003; 37():107-23. PubMed ID: 12795051
[No Abstract] [Full Text] [Related]
5. Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer.
Gridelli C; Maione P; Airoma G; Rossi A
Curr Med Chem; 2002 Nov; 9(21):1851-8. PubMed ID: 12369871
[TBL] [Abstract][Full Text] [Related]
6. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
7. Cyclooxygenase-2 inhibitors and atherosclerosis.
Belton O; Fitzgerald D
J Am Coll Cardiol; 2003 May; 41(10):1820-2. PubMed ID: 12767670
[No Abstract] [Full Text] [Related]
8. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
Romano M; Claria J
FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 and colorectal cancer.
DuBois RN
Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
[No Abstract] [Full Text] [Related]
10. Rationale for use of cyclooxygenase-2 inhibitors in prevention and treatment of bladder cancer.
Pruthi RS; Derksen E; Gaston K; Wallen EM
Urology; 2004 Oct; 64(4):637-42. PubMed ID: 15491687
[No Abstract] [Full Text] [Related]
11. Cyclooxygenase-2 inhibitors in cancer prevention and treatment.
Masferrer JL
Adv Exp Med Biol; 2003; 532():209-13. PubMed ID: 12908559
[No Abstract] [Full Text] [Related]
12. COX-2 inhibitors: a review.
Houston AM; Teach SJ
Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
[No Abstract] [Full Text] [Related]
13. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
14. [COX-2 expression in gastric cancers].
Sakamoto C
Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
[No Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 inhibitors in lung cancer.
Ramalingam S; Belani CP
Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase as a target in lung cancer.
Brown JR; DuBois RN
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4266s-4269s. PubMed ID: 15217972
[TBL] [Abstract][Full Text] [Related]
17. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
18. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
19. Cyclooxygenase-2 inhibitor therapy for the prevention of esophageal adenocarcinoma in Barrett's esophagus.
Gupta RA; DuBois RN
J Natl Cancer Inst; 2002 Mar; 94(6):406-7. PubMed ID: 11904306
[No Abstract] [Full Text] [Related]
20. Introduction. The role of COX-2-specific inhibitors in clinical practice.
Lipsky PE
Am J Med; 2001 Feb; 110 Suppl 3A():1S-2S. PubMed ID: 11173042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
